Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.90+0.14 (+3.72%)
Close on Nov 18, 2026Market cap $94.48MP/E –Yield –
Exagen operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Exagen's operating income for the twelve months ending Jun 30, 2026 was -$13.21M. For fiscal 2025 it was -$14.07M. The highest annual figure on record is -$4.88M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.07M | – |
| FY2024 | Dec 31, 2024 | -$13.64M | – |
| FY2023 | Dec 31, 2023 | -$22.84M | – |
| FY2022 | Dec 31, 2022 | -$46.05M | – |
| FY2021 | Dec 31, 2021 | -$24.07M | – |
| FY2020 | Dec 31, 2020 | -$15.19M | – |
| FY2019 | Dec 31, 2019 | -$9.30M | – |
| FY2018 | Dec 31, 2018 | -$4.88M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.72M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.41M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.10M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.63M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.37M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.38M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.59M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.00M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.07M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.92M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.82M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.06M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.68M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.50M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.74M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.57M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.79M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.42M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.86M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.16M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.41M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.87M | – |
| Q4 FY2018 | Dec 31, 2018 | -$151.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.13M | – |
See a number that looks wrong?